World-leading cancer researchers announce plans to create a new generation of treatments that target the ecosystems supporting cancer. Their new strategy sees cancer genetics and evolution within complex ecosystems as keys to creating new targeted drugs and immunotherapies. They aim to double survival for people with advanced cancer within a decade by combining existing treatments and using smart dosing strategies

A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.

Scientists have identified a new treatment combination that is highly effective at suppressing the growth of head and neck tumours.